Schmidt H, Witthöft C
Leber Magen Darm. 1976 Aug;6(4):227-34.
After a review of the literature the author's results of testing pancreatic function in 445 patients with different diseases are reported. The activities of serum amylase and lipase were estimated before and after stimulation with secretin and pancreozymin; at the same time exocrine secretions of the pancreas were collected in the duodenum and analyzed. Serum enzyme activity did not change markedly after stimulation in pronounced pancreatic insufficiency. Measuring the enzyme activity thus helped to make the diagnosis only in a few cases with chronic pancreatitis and pancreatic carcinoma. In all other patients there was no correlation between changes of serum enzyme activities and changes of exocrine pancreatic function. Pathological test results, that means an increase in enzyme activity after stimulation, were found not only in patients with established or suspected pancreatic diseases, but also in many other subjects. Thus the diagnostic relevance of these tests seems to be rather limited, since it does not prove or exclude with sufficient specificity or adequate probability the presence of pancreatic diseases; it therefore cannot be recommended for screening purposes.
在回顾文献之后,报告了作者对445例患有不同疾病患者的胰腺功能测试结果。在用促胰液素和胰酶泌素刺激前后,对血清淀粉酶和脂肪酶的活性进行了评估;与此同时,收集十二指肠中的胰腺外分泌液并进行分析。在明显的胰腺功能不全患者中,刺激后血清酶活性没有明显变化。因此,仅在少数慢性胰腺炎和胰腺癌病例中,通过测量酶活性有助于做出诊断。在所有其他患者中,血清酶活性变化与胰腺外分泌功能变化之间没有相关性。不仅在已确诊或疑似胰腺疾病的患者中,而且在许多其他受试者中,都发现了病理测试结果,即刺激后酶活性增加。因此,这些测试的诊断相关性似乎相当有限,因为它不能以足够的特异性或适当的概率证明或排除胰腺疾病的存在;因此,不建议将其用于筛查目的。